Anti-CALR3/ CMH19/ CRT2 functional antibody

Anti-CALR3/ CMH19/ CRT2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CALR3/CALR3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1671-Ab-1/ GM-Tg-hg-SE1671-Ab-2Anti-Human CALR3 monoclonal antibodyHuman
GM-Tg-rg-SE1671-Ab-1/ GM-Tg-rg-SE1671-Ab-2Anti-Rat CALR3 monoclonal antibodyRat
GM-Tg-mg-SE1671-Ab-1/ GM-Tg-mg-SE1671-Ab-2Anti-Mouse CALR3 monoclonal antibodyMouse
GM-Tg-cynog-SE1671-Ab-1/ GM-Tg-cynog-SE1671-Ab-2Anti-Cynomolgus/ Rhesus macaque CALR3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1671-Ab-1/ GM-Tg-felg-SE1671-Ab-2Anti-Feline CALR3 monoclonal antibodyFeline
GM-Tg-cang-SE1671-Ab-1/ GM-Tg-cang-SE1671-Ab-2Anti-Canine CALR3 monoclonal antibodyCanine
GM-Tg-bovg-SE1671-Ab-1/ GM-Tg-bovg-SE1671-Ab-2Anti-Bovine CALR3 monoclonal antibodyBovine
GM-Tg-equg-SE1671-Ab-1/ GM-Tg-equg-SE1671-Ab-2Anti-Equine CALR3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1671-Ab-1/ GM-Tg-hg-SE1671-Ab-2; GM-Tg-rg-SE1671-Ab-1/ GM-Tg-rg-SE1671-Ab-2;
GM-Tg-mg-SE1671-Ab-1/ GM-Tg-mg-SE1671-Ab-2; GM-Tg-cynog-SE1671-Ab-1/ GM-Tg-cynog-SE1671-Ab-2;
GM-Tg-felg-SE1671-Ab-1/ GM-Tg-felg-SE1671-Ab-2; GM-Tg-cang-SE1671-Ab-1/ GM-Tg-cang-SE1671-Ab-2;
GM-Tg-bovg-SE1671-Ab-1/ GM-Tg-bovg-SE1671-Ab-2; GM-Tg-equg-SE1671-Ab-1/ GM-Tg-equg-SE1671-Ab-2
Products NameAnti-CALR3 monoclonal antibody
Formatmab
Target NameCALR3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CALR3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1671-Ag-1Recombinant multi-species CALR3/ CMH19/ CRT2 protein


    Target information

    Target IDGM-SE1671
    Target NameCALR3
    Gene ID125972,73316,364529,719532,476680,101100949,508555,100069862
    Gene Symbol and Synonyms1700031L01Rik,6330586I20Rik,CALR3,CMH19,CRT2,cspn,CT93
    Uniprot AccessionQ96L12,Q2TBR8
    Uniprot Entry NameCALR3_HUMAN,CALR3_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000269058
    Target ClassificationN/A

    The target: CALR3, gene name: CALR3, also named as CMH19, CRT2, CT93. The protein encoded by this gene belongs to the calreticulin family, members of which are calcium-binding chaperones localized mainly in the endoplasmic reticulum. This protein is also localized to the endoplasmic reticulum lumen, however, its capacity for calcium-binding may be absent or much lower than other family members. This gene is specifically expressed in the testis, and may be required for sperm fertility. Mutation in this gene has been associated with familial hypertrophic cardiomyopathy. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.